The Federal Trade Commission sued Nate Jones and Xlear Corporation over marketing and studies of nasal sprays and gargles against SARS-CoV-2

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.